RALEIGH, N.C. and WASHINGTON, April 14, 2015 /PRNewswire/ -- Rome Foundation, the pre-eminent global source for protocols to diagnose and treat functional gastroenterology disorders (FGIDs), and LogicNets, the developer of the LogicNets decision support automation platform, announced TODAY the formation of a new strategic partnership. The two organizations plan to jointly develop and make available to clinicians and practitioners worldwide an advanced online decision support system for Rome's next generation multi-dimensional clinical profiles (MDCP) protocols. The LogicNets platform's visual modeling capability is expected to greatly improve the ability of Rome members – who are leading experts in the field of Gastroenterology – to capture their expertise so that it can be shared through an online interactive system with a worldwide medical community. It is also expected to enhance the ability of practitioners around the world to successfully access Rome expertise, diagnose and treat patients, increase their own knowledge and credentials, and contribute to outcomes-based learning facilitated by the planned system.
Practitioners treating FGIDs have relied on "the Rome Criteria" for over 20 years to properly diagnose FGIDs. During that period, the Rome Algorithms have been available in traditional and online publications including dedicated issues of the American Journal of Gastroenterology. However, as knowledge in the field has progressed, Rome has recognized the need to employ a new multi-dimensional model to capture the full dimensionality of the patient's illness in order to better target the treatment. This involves the need to integrate not only the Rome diagnosis, but also the psychological, physiological, quality of life and other factors that contribute to planning treatment. While empirically used by expert clinicians, these factors have not previously been articulated in a clear and comprehensive form prior to the development of the MDCP. This new reality greatly increases the sophistication and complexity of FGIDs treatment protocols and has led Rome to search for a platform capable of interactively guiding practitioners through the diagnostic and treatment pathways to achieve the optimal outcomes.
"Our new MDCP methodology for treating functional GI disorders represents a phenomenal step forward in bringing practitioners up to speed with the latest understanding of the science and of the intricate biopsychosocial relationships that contribute to the illness experience and it provides, for the first time, the means to optimize treatment," noted Dr. Douglas A. Drossman MD, President of the Rome Foundation. "However, having a significantly more sophisticated approach has highlighted the fact that our traditional methods for delivering such learning systems to practitioners are simply not effective enough. We realized we needed a decision support system that could allow us to intelligently guide practitioners through the considerably more complex decision making pathways of the MDCP. LogicNets provided a platform that our members could work with to capture the new layers of complexity and which could deliver it online in a user-friendly format, guiding users and heuristically learning from their experiences to constantly improve the effectiveness of the protocols."
"We are thrilled that the Rome Foundation -- which is so important and highly regarded in the global clinical community -- has chosen to work with us and it underscores how fundamental the role of clinical decision support applications is becoming," said Jelle Ferwerda, CEO and Founder of LogicNets. "We are extremely excited by the great benefits that our platform will bring to making practitioners more effective and informed."
While details are in progress, the organizations plan to target Rome's 2016 release of the second edition of the MDCP containing the ROME IV Criteria and diagnostic algorithms as a launch date for the first generally available version of the LogicNets-based platform.
About the Rome Foundation
The Rome Foundation is an independent not for profit 501(c) 3 organization that provides support for activities designed to create scientific data and educational information to assist in the diagnosis and treatment of functional gastrointestinal disorders (FGIDs). Our mission is to improve the lives of people with functional GI disorders.
Over the last 20 years, the Rome organization has sought to legitimize and update knowledge of the FGIDs. This has been accomplished by bringing together scientists and clinicians from around the world to classify and critically appraise the science of gastrointestinal function and dysfunction. This knowledge permits clinical scientists to make recommendations for diagnosis and treatment that can be applied in research and clinical practice.
The Rome Foundation is committed to the continuous development, legitimization and preservation of the field of FGIDs through science-based activities. We are inclusive and collaborative, patient-centered, innovative and open to new ideas.
Since 2004, LogicNets has focused on developing its LogicNets Expert Decision Support platform allowing organizations to capture their expertise and make it available on-demand to all staff, partners, and customers via online applications accessible from any location or standard device. The LogicNets Clinical Decision Support Platform is offered either as a cloud-based hosted service (SaaS) or a locally installed web-enabled application. For more information on LogicNets, please visit http://medical.logicnets.com
Patrick Dowling, VP Business Development
LogicNets and the LogicNets logo are trademarks of LogicNets Inc. All other product and company names herein may be trademarks of their respective owners.
SOURCE LogicNets, Inc.